source
- Novo outlines plan for multiple new drugs to regain market share as shares dip 8%At a capital markets day in London, Novo executives presented a roadmap to launch more than five multi-blockbuster drugs by 2030 and target $23 billion in annual sales by 2035, aiming to offset the…
- Pfizer and Eli Lilly sign 'most favored nation' pricing deals to share foreign price hikes with US governmentPfizer and Eli Lilly have entered into “most favored nation” agreements with the Trump administration, according to a recent report. The deals require the two companies to remit a portion of the a…